U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $123.33 Average PT from Analysts

Posted by Defense World Staff on Oct 20th, 2023

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) have received an average recommendation of “Buy” from the four ratings firms that are presently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $123.33.

A number of research firms have recently issued reports on USPH. JPMorgan Chase & Co. began coverage on shares of U.S. Physical Therapy in a research report on Friday, September 22nd. They issued an “overweight” rating and a $108.00 price target on the stock. Barrington Research raised their price target on shares of U.S. Physical Therapy from $116.00 to $124.00 and gave the stock an “outperform” rating in a research report on Monday, August 14th. TheStreet downgraded shares of U.S. Physical Therapy from a “b-” rating to a “c+” rating in a research report on Wednesday, October 4th. CJS Securities raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating in a report on Tuesday, September 19th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday.

Read Our Latest Analysis on USPH

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 4,114 shares of the firm’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $109.99, for a total transaction of $452,498.86. Following the transaction, the chief operating officer now owns 7,577 shares of the company’s stock, valued at approximately $833,394.23. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, COO Graham D. Reeve sold 4,114 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $109.99, for a total value of $452,498.86. Following the transaction, the chief operating officer now owns 7,577 shares of the company’s stock, valued at approximately $833,394.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Edward L. Kuntz sold 1,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, August 14th. The stock was sold at an average price of $107.60, for a total transaction of $107,600.00. Following the completion of the transaction, the director now directly owns 8,280 shares in the company, valued at approximately $890,928. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,114 shares of company stock valued at $670,049. Company insiders own 1.80% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in USPH. Harbor Capital Advisors Inc. acquired a new position in shares of U.S. Physical Therapy in the second quarter worth about $27,000. Huntington National Bank grew its position in U.S. Physical Therapy by 71.8% during the second quarter. Huntington National Bank now owns 280 shares of the company’s stock valued at $34,000 after purchasing an additional 117 shares in the last quarter. Lazard Asset Management LLC grew its position in U.S. Physical Therapy by 754.7% during the first quarter. Lazard Asset Management LLC now owns 453 shares of the company’s stock valued at $45,000 after purchasing an additional 400 shares in the last quarter. Benjamin Edwards Inc. grew its position in U.S. Physical Therapy by 133.0% during the first quarter. Benjamin Edwards Inc. now owns 487 shares of the company’s stock valued at $48,000 after purchasing an additional 278 shares in the last quarter. Finally, Northwest Bank & Trust Co purchased a new position in U.S. Physical Therapy during the second quarter valued at approximately $49,000.

U.S. Physical Therapy Trading Up 0.5 %

NYSE USPH opened at $88.64 on Tuesday. U.S. Physical Therapy has a 12 month low of $78.17 and a 12 month high of $124.11. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.82 and a quick ratio of 2.82. The company has a market capitalization of $1.33 billion, a price-to-earnings ratio of 45.93, a price-to-earnings-growth ratio of 4.36 and a beta of 1.37. The company’s fifty day moving average price is $95.88 and its two-hundred day moving average price is $105.81.

U.S. Physical Therapy (NYSE:USPH – Get Free Report) last posted its quarterly earnings data on Tuesday, August 8th. The company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.74 by $0.02. U.S. Physical Therapy had a net margin of 5.25% and a return on equity of 9.22%. The firm had revenue of $151.50 million for the quarter, compared to the consensus estimate of $151.06 million. During the same period in the prior year, the firm posted $0.90 EPS. The firm’s revenue was up 7.7% compared to the same quarter last year. As a group, research analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 8th. Shareholders of record on Friday, August 18th were paid a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, August 17th. This represents a $1.72 annualized dividend and a yield of 1.94%. U.S. Physical Therapy’s payout ratio is 89.12%.

U.S. Physical Therapy Company Profile

(Get Free Report

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.